| Trial ID: | L0843 |
| Source ID: | NCT02875392
|
| Associated Drug: |
Fucoidan
|
| Title: |
Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease;Non-alcoholic Fatty Liver Disease;Non-alcoholic Fatty Liver Disease;Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Other: 275mg Oligo Fucoidan + 275mg HS Fucoxanthin;Other: placebo pills;Other: 275mg Oligo Fucoidan + 275mg HS Fucoxanthin;Other: placebo pills;Other: 275mg Oligo Fucoidan + 275mg HS Fucoxanthin;Other: placebo pills;Other: 275mg Oligo Fucoidan + 275mg HS
|
| Outcome Measures: |
improvement on AST;improvement on ALT;improvement on AST;improvement on ALT;improvement on AST;improvement on ALTnan
|
| Sponsor/Collaborators: |
Taipei Medical University WanFang Hospital
|
| Gender: |
All
|
| Age: |
20 Years75 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).
|
| Start Date: |
05/08/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
Taiwan;Taiwan;Taiwan;Taiwan;Taiwan
|
| URL: |
https://clinicaltrials.gov/show/NCT02875392
|
